NDAORAL-28TABLETPriority Review
Approved
Nov 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 9h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NORINYL 1+50 is a combination oral contraceptive containing mestranol (estrogen) and norethindrone (progestin) in a 28-day tablet formulation. It prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial properties. This product is a foundational hormonal contraceptive from the 1960s era.
LOE Approaching
This legacy product faces LOE with moderate competitive pressure (30/100), signaling a shrinking team and transition focus toward generic management or lifecycle extension strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
NORINYL 1+50 offers minimal career growth; roles focus on sustaining a declining franchise through cost optimization and regulatory compliance rather than innovation. Working on this product is suited for professionals managing mature portfolios or seeking stable, lower-visibility assignments within larger organizations.
Brand Manager (Legacy/Mature Products)Regulatory Affairs Specialist
Worked on NORINYL 1+50 28-DAY at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.